Korean J Ophthalmol > Volume 34(5); 2020 > Article
Korean Journal of Ophthalmology 2020;34(5):398-403.
DOI: https://doi.org/10.3341/kjo.2020.0006    Published online October 5, 2020.
Serum Cystatin C Concentrations in Patients with Graves’ Ophthalmopathy
Nagehan Can1, Ercan Ozsoy2, Sabiha Gungor Kobat3, Elif Yusufoglu3, Nevin Ilhan4, Tamer Demir5
1Department of Ophthalmology, Torbali State Hospital, Izmir, Turkey
2Department of Ophthalmology, Haseki Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
3Department of Ophthalmology, Elazıg Training and Research Hospital, University of Health Sciences, Elazıg, Turkey
4Department of Biochemistry, Firat University School of Medicine, Elazıg, Turkey
5Department of Ophthalmology, Canakkale Onsekiz Mart University School of Medicine, Canakkale, Turkey
Correspondence:  Ercan Ozsoy, Tel: 90-212-529-4400, Fax: 90-212-589-6229, 
Email: ercanozy@hotmail.com
Received: 23 January 2020   • Revised: 9 April 2020   • Accepted: 23 April 2020
Abstract
Purpose
To evaluate the concentration of serum cystatin C (CysC) in patients with Graves’ ophthalmopathy (GO) and the usability of the serum CysC concentrations in the follow-up of the disease.
Methods
Thirty patients with GO and 30 healthy age-matched volunteers were included in this cross-sectional study. GO was diagnosed based on the European Group on Graves’ Orbitopathy consensus. Serum thyroid-stimulating hormone, free triiodothyronine, free thyroxine, and CysC concentrations were measured in the participants. The serum CysC concentrations were compared between patients with GO and controls. Patients with GO were subdivided into hyperthyroid and euthyroid patients, and their serum CysC concentrations were compared. In addition, the CysC concentrations in hyperthyroid and euthyroid patients with GO were compared separately with those of healthy subjects. Kruskal-Wallis test and Student’s t-test were used for statistical evaluation.
Results
The mean serum CysC concentrations in GO patients and controls were 1.04 ± 0.36 and 0.74 ± 0.09 mg/L, respectively. There was a statistically significant difference in the serum CysC concentrations between patients with GO and control subjects (p < 0.001). Fifteen patients had hyperthyroid status, and 15 patients had euthyroid status. The mean serum CysC concentrations in hyperthyroid and euthyroid patients with GO were 1.35 ± 0.22 and 0.72 ± 0.13 mg/L, respectively. Serum CysC concentrations were significantly higher in hyperthyroid patients than in euthyroid patients (p = 0.001). In addition, hyperthyroid patients had significantly higher serum CysC concentrations than healthy subjects. Among patients with GO, 21 and nine had mild and moderate-to-severe GO, respectively. Active and inactive GO were observed in eight and 22 patients, respectively.
Conclusions
The serum CysC concentrations in hyperthyroid patients were higher than those in healthy subjects. Moreover, hyperthyroid patients had higher serum CysC concentrations than euthyroid patients. Further studies with a larger sample size are needed to confirm these results.
Key Words: Cystatin C, Exophthalmos, Serum, Thyroxine, Triiodothyronine


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos@ophthalmology.org                

Copyright © 2020 by Korean Ophthalmological Society. All rights reserved.

Developed in M2community

Close layer
prev next